155 related articles for article (PubMed ID: 1555609)
1. Medical treatment of peripheral vascular disease: good or bad?
Duprez D; Clement DL
Eur Heart J; 1992 Feb; 13(2):149-51. PubMed ID: 1555609
[TBL] [Abstract][Full Text] [Related]
2. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
3. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
4. [Experiences with solcoseryl in treatment of stage II peripheral arterial occlusive disease--assessment of clinical effectiveness].
Horsch S; Claeys L
Vasa Suppl; 1992; 35():151-2. PubMed ID: 1481024
[No Abstract] [Full Text] [Related]
5. Drug treatment of peripheral arterial disease in the elderly.
Aronow WS
Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
[TBL] [Abstract][Full Text] [Related]
6. Peripheral arterial disease: drug therapy.
Schwartz JB
J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
[No Abstract] [Full Text] [Related]
7. Pharmacologic management of peripheral vascular disease.
McNamara DB; Champion HC; Kadowitz PJ
Surg Clin North Am; 1998 Jun; 78(3):447-64. PubMed ID: 9673656
[TBL] [Abstract][Full Text] [Related]
8. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs in peripheral arterial disease.
Tulsyan N; Ouriel K; Kashyap VS
Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
[TBL] [Abstract][Full Text] [Related]
10. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
Wahl DG; Simon JP; Robin B; Walker P; Jouanny P; Escanye JM; Paille F; Schmidt C; Brunotte F; Robert J
Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
[TBL] [Abstract][Full Text] [Related]
11. [Drug therapy in peripheral arterial occlusive disease].
Bollinger A
Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
[TBL] [Abstract][Full Text] [Related]
12. [Routine ankle brachial pressure index measurement for peripheral artery disease diagnosis in internal medicine department: Comparison with the recommendations of the Haute Autorité de Santé. Prospective descriptive study about 106 patients].
Vinit J; Bielefeld P; Muller G; Bonnotte B; Lorcerie B; Besancenot JF; Terriat B
Presse Med; 2011 Apr; 40(4 Pt 1):e163-72. PubMed ID: 21255964
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for peripheral arterial disease: emerging therapeutic options.
Jaff MR
Angiology; 2002; 53(6):627-33. PubMed ID: 12463615
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
15. [Prostaglandin E1 in intermittent claudication].
Scheffler P; de la Hamette D; Rogatti W
Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
[No Abstract] [Full Text] [Related]
16. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
König FK
Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
[No Abstract] [Full Text] [Related]
17. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
Boissel JP
Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1721-4. PubMed ID: 1837446
[TBL] [Abstract][Full Text] [Related]
18. Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
Regensteiner JG; Stewart KJ
Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):604-10. PubMed ID: 17063165
[TBL] [Abstract][Full Text] [Related]
19. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
Heidrich H
Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C
Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
[No Abstract] [Full Text] [Related]
[Next] [New Search]